A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall …

DM Zylla, J Eklund, G Gilmore, A Gavenda… - Supportive Care in …, 2021 - Springer
Purpose The prevalence of medical cannabis (MC) use in patients with cancer is growing,
but questions about safety, efficacy, and dosing remain. Conducting randomized, controlled …

[PDF][PDF] A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and …

DM Zylla, J Eklund, G Gilmore, A Gavenda… - sgcm-sscm.ch
Purpose The prevalence of medical cannabis (MC) use in patients with cancer is growing,
but questions about safety, efficacy, and dosing remain. Conducting randomized, controlled …

A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall …

DM Zylla, J Eklund, G Gilmore, A Gavenda… - 2021 - cabidigitallibrary.org
Purpose: The prevalence of medical cannabis (MC) use in patients with cancer is growing,
but questions about safety, efficacy, and dosing remain. Conducting randomized, controlled …

A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall …

DM Zylla, J Eklund, G Gilmore, G Alissa… - Supportive Care in …, 2021 - search.proquest.com
Purpose The prevalence of medical cannabis (MC) use in patients with cancer is growing,
but questions about safety, efficacy, and dosing remain. Conducting randomized, controlled …

A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall …

DM Zylla, J Eklund, G Gilmore… - Supportive Care in …, 2021 - search.ebscohost.com
Purpose: The prevalence of medical cannabis (MC) use in patients with cancer is growing,
but questions about safety, efficacy, and dosing remain. Conducting randomized, controlled …

A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall …

DM Zylla, J Eklund, G Gilmore, A Gavenda… - 2021 - pubmed.ncbi.nlm.nih.gov
Purpose The prevalence of medical cannabis (MC) use in patients with cancer is growing,
but questions about safety, efficacy, and dosing remain. Conducting randomized, controlled …

A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall …

DM Zylla, J Eklund, G Gilmore, A Gavenda… - Supportive Care in …, 2021 - europepmc.org
Purpose The prevalence of medical cannabis (MC) use in patients with cancer is growing,
but questions about safety, efficacy, and dosing remain. Conducting randomized, controlled …

A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall …

DM Zylla, J Eklund, G Gilmore, A Gavenda… - Supportive Care in …, 2021 - go.gale.com
Purpose The prevalence of medical cannabis (MC) use in patients with cancer is growing,
but questions about safety, efficacy, and dosing remain. Conducting randomized, controlled …

A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall …

DM Zylla, J Eklund, G Gilmore, A Gavenda… - Supportive Care in …, 2021 - experts.umn.edu
Purpose: The prevalence of medical cannabis (MC) use in patients with cancer is growing,
but questions about safety, efficacy, and dosing remain. Conducting randomized, controlled …